Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

被引：0

作者：

Piero Barbanti

Cinzia Aurilia

Gabriella Egeo

Stefania Proietti

Florindo D’Onofrio

Paola Torelli

Marco Aguggia

Davide Bertuzzo

Cinzia Finocchi

Michele Trimboli

Sabina Cevoli

Giulia Fiorentini

Bianca Orlando

Maurizio Zucco

Laura Di Clemente

Ilaria Cetta

Bruno Colombo

Monica Laura Bandettini di Poggio

Valentina Favoni

Licia Grazzi

Antonio Salerno

Antonio Carnevale

Micaela Robotti

Fabio Frediani

Claudia Altamura

Massimo Filippi

Fabrizio Vernieri

Stefano Bonassi

机构：

[1] IRCCS San Raffaele Roma,Headache and Pain Unit

[2] San Raffaele University,Clinical and Molecular Epidemiology

[3] IRCCS San Raffaele Roma,Headache Center Neurology Unit

[4] San Giuseppe Moscati Hospital,Unit of Neurology, Department of Medicine and Surgery, Headache Center

[5] University of Parma,Headache Center

[6] Headache Center Cardinal Massaia,Neurology Unit, IRCCS San Raffaele Scientific Institute

[7] Divisione di Neurologia,Neuroalgology Unit, Headache Center Fondazione

[8] University Magna Graecia,Headache Center

[9] IRCCS Istituto delle Scienze Neurologiche di Bologna,Headache and Neurosonology Unit

[10] San Camillo-Forlanini Hospital,undefined

[11] Vita-Salute San Raffaele University,undefined

[12] IRCCS Ospedale Policlinico San Martino,undefined

[13] IRCCS Istituto Neurologico“Carlo Besta”,undefined

[14] Headache Center San Giovanni Addolorata Hospital,undefined

[15] Headache Center San Filippo Neri Hospital,undefined

[16] ASST Santi Paolo Carlo,undefined

[17] Policlinico Universitario Campus Bio-Medico,undefined

来源：

Journal of Neurology | 2024年 / 271卷

关键词：

Migraine; Treatment; Anti-CGRP mAbs; Responder; Late response; Ultra-late response; Real-life;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2434 / 2443

页数：9

共 50 条

[31] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
Marta Torres-Ferrús
Victor J. Gallardo
Alicia Alpuente
Edoardo Caronna
Eulalia Gine-Cipres
Patricia Pozo-Rosich
Journal of Neurology, 2021, 268 : 3789 - 3798
[32] External validation of the predictive model of response to anti-CGRP monoclonal antibodies in patients with migraine
Gonzalez Martinez, A.
Sanchez-Rodriguez, C.
Pagan, J.
Fernandez Lazaro, I.
Rodrigue-Vico, J. S.
Jaimes Sanchez, A.
Gomez Garcia, A.
Casas Limon, J.
Diaz de Teran, J.
Sastre Real, M.
Membrilla Lopez, J. A.
Latorre, G.
Calle de Miguel, C.
Gil Luque, S.
Trevino-Peinado, C.
Quintas Gutierrez, S.
Heredia, P.
Garcia Azorin, D.
Echavarria Iniguez, A.
Guerrero Peral, A. L.
Sierra-Mencia, A.
Gonzalez Garcia, N.
Porta-Etessam, J.
Gago-Viega, A.
JOURNAL OF HEADACHE AND PAIN, 2024, 25
[33] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
Torres-Ferrus, Marta
Gallardo, Victor J.
Alpuente, Alicia
Caronna, Edoardo
Gine-Cipres, Eulalia
Pozo-Rosich, Patricia
JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
[34] European multicenter study on the use of anti-CGRP monoclonal antibodies in real life for migraine prevention: study cohort description
Caronna, Edoardo
Jose Gallardo, Victor
Alpuente, Alicia
Torres-Ferrus, Marta
Huerta Villanueva, Mariano
Munoz, Albert
Campoy, Sergio
Cuadrado Godia, Elisa
Dorado, Laura
Obach, Victor
Fabregat, Neus
Rodriguez Vico, Jaime
Diaz de Teran, Javier
Membrilla, Javier
Pascual, Julio
Garate, Gabriel
Gago, Ana
Guerrero, Angel
Sanahuja, Jordi
Sanchez Soblechero, Antonio
Lozano Ros, Alberto
Irimia Sieira, Pablo
Sanchez del Rio, Margarita
Echeverria Urabayen, Amaya
Garcia Azorin, David
Gonzalez Osorio, Yesica
Gonzalez Quintanilla, Vicente
Lopez Bravo, Alba
Fernandez Lazaro, Iris
Quintas Gutierrez, Sonia
Gonzalez-Martinez, Alicia
Flores Pina, Belen
Manera Zorrilla-Lequerica, Paula
Jaimes Sanchez, Alex
Garcia Gomez, Andrea
Alvarez Escudero, Rocio
Oterino Duran, Agustin
Velasco Juanes, Fernando
Sifontes, Walter
Rodriguez Montolio, Joana
Nieves Castellanos, Candela
Olivier, Marina
Layos-Romero, Almudena
Andres Lopez, Alberto
Sanchez Caballero, Francisco
Beltran Blasco, Isabel
Millan Vazquez, Manuel
Lamas Perez, Raquel
Viguera Romero, Javier
Santos-Lasaosa, Sonia
CEPHALALGIA, 2023, 43 (1supp)
[35] Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
Pellesi, Lanfranco
Guerzoni, Simona
Pini, Luigi Alberto
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 534 - 547
[36] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Grazzi, Licia
Giossi, Riccardo
Montisano, Danilo Antonio
Canella, Mattia
Marcosano, Marilena
Altamura, Claudia
Vernieri, Fabrizio
JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
[37] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Licia Grazzi
Riccardo Giossi
Danilo Antonio Montisano
Mattia Canella
Marilena Marcosano
Claudia Altamura
Fabrizio Vernieri
The Journal of Headache and Pain, 25
[38] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
di Cola, Francesca Schiano
Ceccardi, Giulia
Caratozzolo, Salvatore
Bolchini, Marco
Di Pasquale, Michele
Rao, Renata
Padovani, Alessandro
CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
[39] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
van der Arend, Britt W. H.
van Veelen, Nancy
de Ruijter, Joelle E. T.
Olsen, Michael H.
van den Brink, Antoinette Maassen
Terwindt, Gisela M.
CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
[40] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
Lovati, Carlo
Bernasconi, Gianna
Capogrosso, Chiara
Molteni, Laura
Giorgetti, Federica
Dell'Osso, Bernardo
Pantoni, Leonardo
NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767

← 1 2 3 4 5 →